CochLear (OTCMKTS:CHEOY) Rating Lowered to “Strong Sell” at Zacks Research

CochLear (OTCMKTS:CHEOY) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a report released on Monday,Zacks.com reports.

Separately, UBS Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, CochLear currently has a consensus rating of “Hold”.

CochLear Stock Up 3.0%

CHEOY stock opened at $37.83 on Monday. The stock has a 50-day simple moving average of $41.45 and a two-hundred day simple moving average of $66.16. CochLear has a twelve month low of $31.82 and a twelve month high of $105.60.

About CochLear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.